載入...
Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
Multidrug resistance (MDR) is one of the major obstacles to the efficiency of cancer chemotherapy, which often results from the overexpression of drug efflux transporters such as P-glycoprotein (P-gp). In the present study, we determined the effect of dasatinib which was approved for imatinib resist...
Na minha lista:
| 發表在: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622436/ https://ncbi.nlm.nih.gov/pubmed/25482933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384047.2014.987062 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|